TIPE2 and arthritic joint disease: It has been demonstrated that the TIPE2 level is reduced in the PBMCs of patients with systemic lupus erythematosus (SLE), and collagen-induced arthritis (CIA) mice with a negative correlation with the development of arthritis (35, 36).